Article Information
PubMed
Published By
History
- Received March 8, 2005
- Revision received November 12, 2006
- Accepted November 13, 2006
- First published December 20, 2006.
- Version of record published December 20, 2006.
Copyright & Usage
Copyright © 2006 Society for Neuroscience 0270-6474/06/2613287-10$15.00/0
Author Information
- Jianhua Zhang1,
- Lu Zhang2,
- Hongyuan Jiao2,
- Qi Zhang2,
- Dongsheng Zhang2,
- Danwen Lou2,
- Jonathan L. Katz3, and
- Ming Xu2
- 1Division of Neuropathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama 35294,
- 2Department of Anesthesia and Critical Care, University of Chicago, Chicago, Illinois 60637, and
- 3Medications Discovery Research Branch, National Institute on Drug Abuse, Baltimore, Maryland 21224
- Correspondence should be addressed to Dr. Ming Xu, Department of Anesthesia and Critical Care, University of Chicago, Chicago, IL 60637. mxu{at}dacc.uchicago.edu
Author contributions
Disclosures
- Received March 8, 2005.
- Revision received November 12, 2006.
- Accepted November 13, 2006.
-
J.Z. and M.X. are supported by National Institute on Drug Abuse Grants DA14644 and DA17323 and the Epilepsy Foundation of America. We thank D. French for helping with the locomotor activity measurement, Drs. E. Nestler and P. Ulery for kindly providing ΔFosB-positive brain tissues, and Dr. J. McGinty for advice on the anti-leumorphin antibody.
- Correspondence should be addressed to Dr. Ming Xu, Department of Anesthesia and Critical Care, University of Chicago, Chicago, IL 60637. mxu{at}dacc.uchicago.edu
Online Impact